{"id":"https://openalex.org/W2001054003","doi":"https://doi.org/10.3109/00952999108992817","title":"Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence","display_name":"Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence","publication_year":1991,"publication_date":"1991-01-01","ids":{"openalex":"https://openalex.org/W2001054003","doi":"https://doi.org/10.3109/00952999108992817","mag":"2001054003","pmid":"https://pubmed.ncbi.nlm.nih.gov/1862788"},"language":"en","primary_location":{"id":"doi:10.3109/00952999108992817","doi":"https://doi.org/10.3109/00952999108992817","is_oa":false,"landing_page_url":"https://doi.org/10.3109/00952999108992817","pdf_url":null,"source":{"id":"https://openalex.org/S162477232","display_name":"The American Journal of Drug and Alcohol Abuse","issn_l":"0095-2990","issn":["0095-2990","1097-9891"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Drug and Alcohol Abuse","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049945788","display_name":"William W. Weddington","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William W. Weddington","raw_affiliation_strings":["Addiction Research Center, National Institute on Drug Abuse, Baltimore, Maryland 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addiction Research Center, National Institute on Drug Abuse, Baltimore, Maryland 21224","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106235079","display_name":"Barry S. Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry S. Brown","raw_affiliation_strings":["Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034466497","display_name":"Charles A. Haertzen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles A. Haertzen","raw_affiliation_strings":["Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038050362","display_name":"Judith M. Hess","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judith M. Hess","raw_affiliation_strings":["Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080117407","display_name":"Mahaffey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan R. Mahaffey","raw_affiliation_strings":["Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042682752","display_name":"Anne F. Kolar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne F. Kolar","raw_affiliation_strings":["Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047282391","display_name":"Jerome H. Jaffe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerome H. Jaffe","raw_affiliation_strings":["Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addiction Research Center National Institute on Drug Abuse, Baltimore, Maryland, 21224","institution_ids":["https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1327069482"],"apc_list":null,"apc_paid":null,"fwci":5.711,"has_fulltext":false,"cited_by_count":119,"citation_normalized_percentile":{"value":0.96078614,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"17","issue":"2","first_page":"137","last_page":"152"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":0.9760000109672546},{"id":"https://openalex.org/keywords/amantadine","display_name":"amantadine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/desipramine","display_name":"desipramine","score":1.0},{"id":"https://openalex.org/keywords/adjunctive-pharmacotherapy","display_name":"adjunctive pharmacotherapy","score":0.8209999799728394},{"id":"https://openalex.org/keywords/psychotherapy","display_name":"psychotherapy","score":0.8840000033378601},{"id":"https://openalex.org/keywords/cocaine-craving","display_name":"cocaine craving","score":0.7889999747276306},{"id":"https://openalex.org/keywords/cocaine-abstinence","display_name":"cocaine abstinence","score":0.9620000123977661},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.777999997138977},{"id":"https://openalex.org/keywords/subtherapeutic-dosing","display_name":"subtherapeutic dosing","score":0.6859999895095825},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.5180000066757202},{"id":"https://openalex.org/keywords/outpatients","display_name":"outpatients","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C2780250439","wikidata":"https://www.wikidata.org/wiki/Q423288","display_name":"Desipramine","level":4,"score":0.962592363357544},{"id":"https://openalex.org/C2777374534","wikidata":"https://www.wikidata.org/wiki/Q409761","display_name":"Amantadine","level":2,"score":0.8725134134292603},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.5252649188041687},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5027587413787842},{"id":"https://openalex.org/C2779796075","wikidata":"https://www.wikidata.org/wiki/Q3743188","display_name":"Cocaine dependence","level":3,"score":0.46376559138298035},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4234876036643982},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32203003764152527},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.23439037799835205},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.16193443536758423},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.07904988527297974},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000547","descriptor_name":"Amantadine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000547","descriptor_name":"Amantadine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003891","descriptor_name":"Desipramine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003891","descriptor_name":"Desipramine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011613","descriptor_name":"Psychotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3109/00952999108992817","doi":"https://doi.org/10.3109/00952999108992817","is_oa":false,"landing_page_url":"https://doi.org/10.3109/00952999108992817","pdf_url":null,"source":{"id":"https://openalex.org/S162477232","display_name":"The American Journal of Drug and Alcohol Abuse","issn_l":"0095-2990","issn":["0095-2990","1097-9891"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Drug and Alcohol Abuse","raw_type":"journal-article"},{"id":"pmid:1862788","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1862788","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of drug and alcohol abuse","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W87542944","https://openalex.org/W1970400568","https://openalex.org/W1974702488","https://openalex.org/W1978768979","https://openalex.org/W1984680066","https://openalex.org/W1985598099","https://openalex.org/W2002335181","https://openalex.org/W2005239439","https://openalex.org/W2014725718","https://openalex.org/W2023524736","https://openalex.org/W2024090684","https://openalex.org/W2024538142","https://openalex.org/W2024899357","https://openalex.org/W2028984736","https://openalex.org/W2030078771","https://openalex.org/W2040136430","https://openalex.org/W2045196759","https://openalex.org/W2049165791","https://openalex.org/W2050691698","https://openalex.org/W2051458735","https://openalex.org/W2055730144","https://openalex.org/W2067495470","https://openalex.org/W2074494634","https://openalex.org/W2081320034","https://openalex.org/W2086883657","https://openalex.org/W2090811746","https://openalex.org/W2111325297","https://openalex.org/W2144961582","https://openalex.org/W2148046010","https://openalex.org/W2227188615","https://openalex.org/W2410278931","https://openalex.org/W2412688669","https://openalex.org/W2415565555","https://openalex.org/W2416279662","https://openalex.org/W2521354201","https://openalex.org/W4237706592","https://openalex.org/W4241392517"],"related_works":["https://openalex.org/W2288337919","https://openalex.org/W2128020995","https://openalex.org/W2156998766","https://openalex.org/W2040456077","https://openalex.org/W2127382059","https://openalex.org/W2006899514","https://openalex.org/W1998206718","https://openalex.org/W2410278931","https://openalex.org/W2094465210","https://openalex.org/W1974022166"],"abstract_inverted_index":{"We":[0],"conducted":[1],"a":[2,39,110,144,164],"single-blind,":[3],"random":[4],"assignment,":[5],"placebo-controlled,":[6],"12-week":[7],"comparison":[8],"of":[9,41,44,51,78,155,161,166,176,181],"desipramine":[10,54,150,162,182],"hydrochloride":[11,14],"and":[12,36,64,85,92,101,134],"amantadine":[13],"as":[15],"adjunctive":[16],"treatments":[17],"to":[18,105,151],"counseling":[19],"for":[20,32,72,99,112,132,146,174],"cocaine":[21,34,74,96,136,156],"dependence.":[22],"Subjects":[23,46],"were":[24,120],"54":[25],"outpatients":[26],"who":[27,37],"met":[28],"DSM":[29],"III-R":[30],"criteria":[31],"active":[33],"dependence":[35],"completed":[38],"minimum":[40],"2":[42],"weeks":[43],"treatment.":[45,106],"treated":[47,148],"with":[48,149],"fixed":[49],"doses":[50],"200":[52],"mg/day":[53,59],"(N":[55,61,66],"=":[56,62,67],"17),":[57],"400":[58],"amantadine-placebo":[60],"16),":[63],"placebo":[65],"21)":[68],"did":[69],"not":[70],"differ":[71],"lifetime":[73,76],"use,":[75,97],"histories":[77],"psychopathology,":[79],"admission":[80],"scores":[81],"on":[82],"psychometric":[83],"assessments,":[84],"sociodemographics.":[86],"All":[87],"treatment":[88,125,175],"groups":[89,126],"demonstrated":[90],"dramatic":[91],"persistent":[93],"decreases":[94],"in":[95,129,163],"craving":[98,131],"cocaine,":[100,133],"psychiatric":[102],"symptoms":[103],"consequent":[104],"Although":[107],"there":[108,119],"was":[109,143,169],"trend":[111,145],"more":[113],"dropouts":[114],"by":[115,139],"subjects":[116,147,168],"taking":[117],"desipramine,":[118],"no":[121],"significant":[122],"differences":[123],"among":[124],"regarding":[127],"retention":[128],"treatment,":[130],"decreased":[135],"use":[137],"confirmed":[138],"urine":[140],"toxicology.":[141],"There":[142],"maintain":[152],"longer":[153],"periods":[154],"abstinence.":[157],"Mean":[158],"plasma":[159],"concentration":[160],"subsample":[165],"our":[167],"less":[170],"than":[171],"that":[172],"recommended":[173],"depression,":[177],"thus":[178],"the":[179],"dosage":[180],"may":[183],"have":[184],"been":[185],"subtherapeutic.":[186]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}